Supplemental Material, Imaging_of_atherosclerosis_Supplemental_material_R1 - The Growing Field of Imaging of Atherosclerosis in Peripheral Arteries

<p>Supplemental Material, Imaging_of_atherosclerosis_Supplemental_material_R1 for The Growing Field of Imaging of Atherosclerosis in Peripheral Arteries by Mattia Cattaneo, Rolf Wyttenbach, Roberto Corti, Daniel Staub, and Augusto Gallino in Angiology</p

Association between anticoagulation practices and length of hospital stay^*.

<p>Association between anticoagulation practices and length of hospital stay^{<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0148348#t004fn002" target="_blank">*</a>}.</p

Patient baseline characteristics (N = 991).

<p>Patient baseline characteristics (N = 991).</p

Associations between anticoagulation practices and clinical outcomes at 6 months.

<p>Associations between anticoagulation practices and clinical outcomes at 6 months.</p

Meta-regression plot for the HR (combined endpoint) per SD of annual mean CCA-IMT change (model 1), by the correlation of baseline and follow-up common CIMT.

<p>The size of each circle represents the precision of the log HR.</p

Forest plots of the HR of the combined endpoint per one SD of average mean CCA-IMT (with 95% CIs).

<p>Panel I: Group A (asymptomatic individuals with three or more CVD risk factors), HR adjusted for age, sex and annual mean CCA-IMT change (model 1). Panel II: Group A (asymptomatic individuals with three or more CVD risk factors), HR adjusted for age, sex, annual mean CCA-IMT change and other CVD risk factors (model 2). Panel III: Group B (asymptomatic individuals with carotid plaques), HR adjusted for age, sex and annual mean CCA-IMT change (model 1). Panel IV: Group B (asymptomatic individuals with carotid plaques), HR adjusted for age, sex, annual mean CCA-IMT change and other CVD risk factors (model 2). Panel V: Group C (individuals with previous CVD events), HR adjusted for age, sex and annual mean CCA-IMT change (model 1). Panel VI: Group C (individuals with previous CVD events), HR adjusted for age, sex, annual mean CCA-IMT change and other CVD risk factors (model 2).</p

Cohorts and subsamples.

<p>Cohorts and subsamples.</p

Inclusion criteria.

<p>Inclusion criteria.</p

Forest plots of the HR of the combined endpoint per one SD of annual mean CCA-IMT change (with 95% CIs).

<p>Panel I: Group A (asymptomatic individuals with three or more CVD risk factors), HR adjusted for age, sex and average mean CCA-IMT (model 1). Panel II: Group A (asymptomatic individuals with three or more CVD risk factors), HR adjusted for age, sex, average mean CCA-IMT and other CVD risk factors (model 2). Panel III: Group B (asymptomatic individuals with carotid plaques), HR adjusted for age, sex and average mean CCA-IMT (model 1). Panel IV: Group B (asymptomatic individuals with carotid plaques), HR adjusted for age, sex, average mean CCA-IMT and other CVD risk factors (model 2). Panel V: Group C (individuals with previous CVD events), HR adjusted for age, sex and average mean CCA-IMT (model 1). Panel VI: Group C (individuals with previous CVD events), HR adjusted for age, sex, average mean CCA-IMT and other CVD risk factors (model 2).</p